世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

月経困難症治療の世界市場成長(現状と展望)2024-2030年


Global Dysmenorrhea Treatment Market Growth (Status and Outlook) 2024-2030

LPI(LPインフォメーション)の最新調査によると、世界の月経困難症治療剤の市場規模は2023年に100万米ドルと評価されました。下流市場での需要の増加に伴い、月経困難症治療薬はレビュー期間中のCAGR %で2030年... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2024年6月21日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
104 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

LPI(LPインフォメーション)の最新調査によると、世界の月経困難症治療剤の市場規模は2023年に100万米ドルと評価されました。下流市場での需要の増加に伴い、月経困難症治療薬はレビュー期間中のCAGR %で2030年までに百万米ドルの再調整サイズになると予測されています。
この調査レポートは、世界の月経困難症治療市場の成長可能性を明らかにしています。月経困難症治療薬は、今後の市場で安定した成長を示すと予想される。しかし、月経困難症治療薬の普及には、製品の差別化、コスト削減、サプライチェーンの最適化が引き続き重要です。市場参加者は、月経困難症治療薬市場がもたらす莫大な機会を活用するために、研究開発に投資し、戦略的パートナーシップを構築し、進化する消費者の嗜好に合わせた製品を提供する必要があります。
月経困難症とは、痛みを伴う月経の一種を指す。
世界の医薬品市場は、2022年には1,475億米ドルとなり、今後6年間のCAGRは5%で成長する。医薬品市場には化学医薬品と生物学的製剤がある。生物製剤は2022年に3810億ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間&政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要としている患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の大流行はワクチン開発とサプライチェーン管理の重要性を浮き彫りにし、製薬企業が公衆衛生の新たなニーズに機敏に対応する必要性をさらに強調している。
主な特徴
月経困難症治療薬市場に関する本レポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。
市場規模と成長:この調査レポートは、月経困難症治療市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分(鎮痛剤、ホルモン療法など)、地域別内訳などが含まれます。
市場の促進要因と課題:当レポートでは、政府の規制、環境問題、技術の進歩、消費者の嗜好の変化など、月経困難症治療薬市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、射程距離への不安、高額な初期費用など、業界が直面する課題も浮き彫りにすることができます。
競合情勢:この調査レポートは、月経困難症治療市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれます。また、新興プレーヤーとその潜在的な市場への影響もハイライトできます。
技術開発:この調査レポートは、月経困難症治療薬業界における最新の技術開発を掘り下げることができます。これには、月経困難症治療技術の進歩、月経困難症治療の新規参入、月経困難症治療の新規投資、月経困難症治療の将来を形作るその他の技術革新が含まれます。
川下の事業者の好み:当レポートは、月経困難症治療市場における顧客の購買行動と採用傾向に光を当てることができます。顧客の購買決定、月経困難症治療製品の嗜好に影響を与える要因も含まれます。
政府の政策とインセンティブこの調査レポートは、政府の政策やインセンティブが月経困難症治療薬市場に与える影響を分析しています。これには、規制の枠組み、補助金、税制優遇措置、その他月経困難症治療薬市場の促進を目的とした施策の評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。
環境への影響と持続可能性当調査レポートでは、月経困難症治療薬市場の環境への影響と持続可能性の側面を評価します。
市場予測と将来展望:調査レポートは、実施した分析に基づいて、月経困難症治療薬産業の市場予測と展望を提供します。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。
提言と機会:本レポートは、業界関係者、政策立案者、投資家への提言で締めくくります。市場関係者が新たなトレンドを活用し、課題を克服し、月経困難症治療薬市場の成長と発展に貢献するための潜在的な機会を強調しています。
市場の細分化
月経困難症治療薬市場は、タイプ別と用途別に分類されます。2019年から2030年までの期間について、セグメント間の成長により、タイプ別、アプリケーション別の消費額の正確な計算と予測を提供します。
タイプ別セグメント
鎮痛剤
ホルモン療法
外科手術
用途別セグメント
病院
クリニック
研究センター
その他
本レポートは地域別にも市場を分割しています:
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、一次専門家から収集したインプットと、企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
メルク社
ノバルティスAG
バイエル
アボット・ラボラトリーズ
ファイザー
ロシュ
TAJファーマ
マイラン製薬
ノーベル製薬
ジュニパー・ファーマシューティカルズ
サノフィ
グラクソ・スミスクライン
ジョンソン・エンド・ジョンソン
フォーカスコンシューマーヘルスケア


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dysmenorrhea Treatment Market Size 2019-2030
2.1.2 Dysmenorrhea Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Dysmenorrhea Treatment Segment by Type
2.2.1 Pain Relievers
2.2.2 Hormonal Therapy
2.2.3 Surgery
2.3 Dysmenorrhea Treatment Market Size by Type
2.3.1 Dysmenorrhea Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Dysmenorrhea Treatment Market Size Market Share by Type (2019-2024)
2.4 Dysmenorrhea Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Research Centers
2.4.4 Others
2.5 Dysmenorrhea Treatment Market Size by Application
2.5.1 Dysmenorrhea Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Dysmenorrhea Treatment Market Size Market Share by Application (2019-2024)
3 Dysmenorrhea Treatment Market Size by Player
3.1 Dysmenorrhea Treatment Market Size Market Share by Players
3.1.1 Global Dysmenorrhea Treatment Revenue by Players (2019-2024)
3.1.2 Global Dysmenorrhea Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Dysmenorrhea Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Dysmenorrhea Treatment by Regions
4.1 Dysmenorrhea Treatment Market Size by Regions (2019-2024)
4.2 Americas Dysmenorrhea Treatment Market Size Growth (2019-2024)
4.3 APAC Dysmenorrhea Treatment Market Size Growth (2019-2024)
4.4 Europe Dysmenorrhea Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Dysmenorrhea Treatment Market Size Growth (2019-2024)
5 Americas
5.1 Americas Dysmenorrhea Treatment Market Size by Country (2019-2024)
5.2 Americas Dysmenorrhea Treatment Market Size by Type (2019-2024)
5.3 Americas Dysmenorrhea Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dysmenorrhea Treatment Market Size by Region (2019-2024)
6.2 APAC Dysmenorrhea Treatment Market Size by Type (2019-2024)
6.3 APAC Dysmenorrhea Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Dysmenorrhea Treatment by Country (2019-2024)
7.2 Europe Dysmenorrhea Treatment Market Size by Type (2019-2024)
7.3 Europe Dysmenorrhea Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dysmenorrhea Treatment by Region (2019-2024)
8.2 Middle East & Africa Dysmenorrhea Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Dysmenorrhea Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Dysmenorrhea Treatment Market Forecast
10.1 Global Dysmenorrhea Treatment Forecast by Regions (2025-2030)
10.1.1 Global Dysmenorrhea Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Dysmenorrhea Treatment Forecast
10.1.3 APAC Dysmenorrhea Treatment Forecast
10.1.4 Europe Dysmenorrhea Treatment Forecast
10.1.5 Middle East & Africa Dysmenorrhea Treatment Forecast
10.2 Americas Dysmenorrhea Treatment Forecast by Country (2025-2030)
10.2.1 United States Dysmenorrhea Treatment Market Forecast
10.2.2 Canada Dysmenorrhea Treatment Market Forecast
10.2.3 Mexico Dysmenorrhea Treatment Market Forecast
10.2.4 Brazil Dysmenorrhea Treatment Market Forecast
10.3 APAC Dysmenorrhea Treatment Forecast by Region (2025-2030)
10.3.1 China Dysmenorrhea Treatment Market Forecast
10.3.2 Japan Dysmenorrhea Treatment Market Forecast
10.3.3 Korea Dysmenorrhea Treatment Market Forecast
10.3.4 Southeast Asia Dysmenorrhea Treatment Market Forecast
10.3.5 India Dysmenorrhea Treatment Market Forecast
10.3.6 Australia Dysmenorrhea Treatment Market Forecast
10.4 Europe Dysmenorrhea Treatment Forecast by Country (2025-2030)
10.4.1 Germany Dysmenorrhea Treatment Market Forecast
10.4.2 France Dysmenorrhea Treatment Market Forecast
10.4.3 UK Dysmenorrhea Treatment Market Forecast
10.4.4 Italy Dysmenorrhea Treatment Market Forecast
10.4.5 Russia Dysmenorrhea Treatment Market Forecast
10.5 Middle East & Africa Dysmenorrhea Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Dysmenorrhea Treatment Market Forecast
10.5.2 South Africa Dysmenorrhea Treatment Market Forecast
10.5.3 Israel Dysmenorrhea Treatment Market Forecast
10.5.4 Turkey Dysmenorrhea Treatment Market Forecast
10.5.5 GCC Countries Dysmenorrhea Treatment Market Forecast
10.6 Global Dysmenorrhea Treatment Forecast by Type (2025-2030)
10.7 Global Dysmenorrhea Treatment Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Merck & Co.
11.1.1 Merck & Co. Company Information
11.1.2 Merck & Co. Dysmenorrhea Treatment Product Offered
11.1.3 Merck & Co. Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Merck & Co. Main Business Overview
11.1.5 Merck & Co. Latest Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Information
11.2.2 Novartis AG Dysmenorrhea Treatment Product Offered
11.2.3 Novartis AG Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis AG Main Business Overview
11.2.5 Novartis AG Latest Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Dysmenorrhea Treatment Product Offered
11.3.3 Bayer Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer Latest Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Information
11.4.2 Abbott Laboratories Dysmenorrhea Treatment Product Offered
11.4.3 Abbott Laboratories Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Abbott Laboratories Main Business Overview
11.4.5 Abbott Laboratories Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Dysmenorrhea Treatment Product Offered
11.5.3 Pfizer Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Dysmenorrhea Treatment Product Offered
11.6.3 Roche Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 TAJ Pharma
11.7.1 TAJ Pharma Company Information
11.7.2 TAJ Pharma Dysmenorrhea Treatment Product Offered
11.7.3 TAJ Pharma Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 TAJ Pharma Main Business Overview
11.7.5 TAJ Pharma Latest Developments
11.8 Mylan Pharmaceuticals
11.8.1 Mylan Pharmaceuticals Company Information
11.8.2 Mylan Pharmaceuticals Dysmenorrhea Treatment Product Offered
11.8.3 Mylan Pharmaceuticals Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Mylan Pharmaceuticals Main Business Overview
11.8.5 Mylan Pharmaceuticals Latest Developments
11.9 Nobel Pharmaceuticals
11.9.1 Nobel Pharmaceuticals Company Information
11.9.2 Nobel Pharmaceuticals Dysmenorrhea Treatment Product Offered
11.9.3 Nobel Pharmaceuticals Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Nobel Pharmaceuticals Main Business Overview
11.9.5 Nobel Pharmaceuticals Latest Developments
11.10 Juniper Pharmaceuticals
11.10.1 Juniper Pharmaceuticals Company Information
11.10.2 Juniper Pharmaceuticals Dysmenorrhea Treatment Product Offered
11.10.3 Juniper Pharmaceuticals Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Juniper Pharmaceuticals Main Business Overview
11.10.5 Juniper Pharmaceuticals Latest Developments
11.11 Sanofi
11.11.1 Sanofi Company Information
11.11.2 Sanofi Dysmenorrhea Treatment Product Offered
11.11.3 Sanofi Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Sanofi Main Business Overview
11.11.5 Sanofi Latest Developments
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Company Information
11.12.2 GlaxoSmithKline Dysmenorrhea Treatment Product Offered
11.12.3 GlaxoSmithKline Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 GlaxoSmithKline Main Business Overview
11.12.5 GlaxoSmithKline Latest Developments
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Information
11.13.2 Johnson & Johnson Dysmenorrhea Treatment Product Offered
11.13.3 Johnson & Johnson Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Johnson & Johnson Main Business Overview
11.13.5 Johnson & Johnson Latest Developments
11.14 Focus Consumer Healthcare
11.14.1 Focus Consumer Healthcare Company Information
11.14.2 Focus Consumer Healthcare Dysmenorrhea Treatment Product Offered
11.14.3 Focus Consumer Healthcare Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Focus Consumer Healthcare Main Business Overview
11.14.5 Focus Consumer Healthcare Latest Developments
12 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

According to our LPI (LP Information) latest study, the global Dysmenorrhea Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Dysmenorrhea Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Dysmenorrhea Treatment market. Dysmenorrhea Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Dysmenorrhea Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Dysmenorrhea Treatment market.
Dysmenorrhea refers to a type of painful menstruation.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Dysmenorrhea Treatment market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Dysmenorrhea Treatment market. It may include historical data, market segmentation by Type (e.g., Pain Relievers, Hormonal Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Dysmenorrhea Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Dysmenorrhea Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Dysmenorrhea Treatment industry. This include advancements in Dysmenorrhea Treatment technology, Dysmenorrhea Treatment new entrants, Dysmenorrhea Treatment new investment, and other innovations that are shaping the future of Dysmenorrhea Treatment.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Dysmenorrhea Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Dysmenorrhea Treatment product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Dysmenorrhea Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Dysmenorrhea Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Dysmenorrhea Treatment market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Dysmenorrhea Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Dysmenorrhea Treatment market.
Market Segmentation:
Dysmenorrhea Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Pain Relievers
Hormonal Therapy
Surgery
Segmentation by application
Hospitals
Clinics
Research Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck & Co.
Novartis AG
Bayer
Abbott Laboratories
Pfizer
Roche
TAJ Pharma
Mylan Pharmaceuticals
Nobel Pharmaceuticals
Juniper Pharmaceuticals
Sanofi
GlaxoSmithKline
Johnson & Johnson
Focus Consumer Healthcare



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dysmenorrhea Treatment Market Size 2019-2030
2.1.2 Dysmenorrhea Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Dysmenorrhea Treatment Segment by Type
2.2.1 Pain Relievers
2.2.2 Hormonal Therapy
2.2.3 Surgery
2.3 Dysmenorrhea Treatment Market Size by Type
2.3.1 Dysmenorrhea Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Dysmenorrhea Treatment Market Size Market Share by Type (2019-2024)
2.4 Dysmenorrhea Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Research Centers
2.4.4 Others
2.5 Dysmenorrhea Treatment Market Size by Application
2.5.1 Dysmenorrhea Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Dysmenorrhea Treatment Market Size Market Share by Application (2019-2024)
3 Dysmenorrhea Treatment Market Size by Player
3.1 Dysmenorrhea Treatment Market Size Market Share by Players
3.1.1 Global Dysmenorrhea Treatment Revenue by Players (2019-2024)
3.1.2 Global Dysmenorrhea Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Dysmenorrhea Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Dysmenorrhea Treatment by Regions
4.1 Dysmenorrhea Treatment Market Size by Regions (2019-2024)
4.2 Americas Dysmenorrhea Treatment Market Size Growth (2019-2024)
4.3 APAC Dysmenorrhea Treatment Market Size Growth (2019-2024)
4.4 Europe Dysmenorrhea Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Dysmenorrhea Treatment Market Size Growth (2019-2024)
5 Americas
5.1 Americas Dysmenorrhea Treatment Market Size by Country (2019-2024)
5.2 Americas Dysmenorrhea Treatment Market Size by Type (2019-2024)
5.3 Americas Dysmenorrhea Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dysmenorrhea Treatment Market Size by Region (2019-2024)
6.2 APAC Dysmenorrhea Treatment Market Size by Type (2019-2024)
6.3 APAC Dysmenorrhea Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Dysmenorrhea Treatment by Country (2019-2024)
7.2 Europe Dysmenorrhea Treatment Market Size by Type (2019-2024)
7.3 Europe Dysmenorrhea Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dysmenorrhea Treatment by Region (2019-2024)
8.2 Middle East & Africa Dysmenorrhea Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Dysmenorrhea Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Dysmenorrhea Treatment Market Forecast
10.1 Global Dysmenorrhea Treatment Forecast by Regions (2025-2030)
10.1.1 Global Dysmenorrhea Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Dysmenorrhea Treatment Forecast
10.1.3 APAC Dysmenorrhea Treatment Forecast
10.1.4 Europe Dysmenorrhea Treatment Forecast
10.1.5 Middle East & Africa Dysmenorrhea Treatment Forecast
10.2 Americas Dysmenorrhea Treatment Forecast by Country (2025-2030)
10.2.1 United States Dysmenorrhea Treatment Market Forecast
10.2.2 Canada Dysmenorrhea Treatment Market Forecast
10.2.3 Mexico Dysmenorrhea Treatment Market Forecast
10.2.4 Brazil Dysmenorrhea Treatment Market Forecast
10.3 APAC Dysmenorrhea Treatment Forecast by Region (2025-2030)
10.3.1 China Dysmenorrhea Treatment Market Forecast
10.3.2 Japan Dysmenorrhea Treatment Market Forecast
10.3.3 Korea Dysmenorrhea Treatment Market Forecast
10.3.4 Southeast Asia Dysmenorrhea Treatment Market Forecast
10.3.5 India Dysmenorrhea Treatment Market Forecast
10.3.6 Australia Dysmenorrhea Treatment Market Forecast
10.4 Europe Dysmenorrhea Treatment Forecast by Country (2025-2030)
10.4.1 Germany Dysmenorrhea Treatment Market Forecast
10.4.2 France Dysmenorrhea Treatment Market Forecast
10.4.3 UK Dysmenorrhea Treatment Market Forecast
10.4.4 Italy Dysmenorrhea Treatment Market Forecast
10.4.5 Russia Dysmenorrhea Treatment Market Forecast
10.5 Middle East & Africa Dysmenorrhea Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Dysmenorrhea Treatment Market Forecast
10.5.2 South Africa Dysmenorrhea Treatment Market Forecast
10.5.3 Israel Dysmenorrhea Treatment Market Forecast
10.5.4 Turkey Dysmenorrhea Treatment Market Forecast
10.5.5 GCC Countries Dysmenorrhea Treatment Market Forecast
10.6 Global Dysmenorrhea Treatment Forecast by Type (2025-2030)
10.7 Global Dysmenorrhea Treatment Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Merck & Co.
11.1.1 Merck & Co. Company Information
11.1.2 Merck & Co. Dysmenorrhea Treatment Product Offered
11.1.3 Merck & Co. Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Merck & Co. Main Business Overview
11.1.5 Merck & Co. Latest Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Information
11.2.2 Novartis AG Dysmenorrhea Treatment Product Offered
11.2.3 Novartis AG Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis AG Main Business Overview
11.2.5 Novartis AG Latest Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Dysmenorrhea Treatment Product Offered
11.3.3 Bayer Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer Latest Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Information
11.4.2 Abbott Laboratories Dysmenorrhea Treatment Product Offered
11.4.3 Abbott Laboratories Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Abbott Laboratories Main Business Overview
11.4.5 Abbott Laboratories Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Dysmenorrhea Treatment Product Offered
11.5.3 Pfizer Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Dysmenorrhea Treatment Product Offered
11.6.3 Roche Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 TAJ Pharma
11.7.1 TAJ Pharma Company Information
11.7.2 TAJ Pharma Dysmenorrhea Treatment Product Offered
11.7.3 TAJ Pharma Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 TAJ Pharma Main Business Overview
11.7.5 TAJ Pharma Latest Developments
11.8 Mylan Pharmaceuticals
11.8.1 Mylan Pharmaceuticals Company Information
11.8.2 Mylan Pharmaceuticals Dysmenorrhea Treatment Product Offered
11.8.3 Mylan Pharmaceuticals Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Mylan Pharmaceuticals Main Business Overview
11.8.5 Mylan Pharmaceuticals Latest Developments
11.9 Nobel Pharmaceuticals
11.9.1 Nobel Pharmaceuticals Company Information
11.9.2 Nobel Pharmaceuticals Dysmenorrhea Treatment Product Offered
11.9.3 Nobel Pharmaceuticals Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Nobel Pharmaceuticals Main Business Overview
11.9.5 Nobel Pharmaceuticals Latest Developments
11.10 Juniper Pharmaceuticals
11.10.1 Juniper Pharmaceuticals Company Information
11.10.2 Juniper Pharmaceuticals Dysmenorrhea Treatment Product Offered
11.10.3 Juniper Pharmaceuticals Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Juniper Pharmaceuticals Main Business Overview
11.10.5 Juniper Pharmaceuticals Latest Developments
11.11 Sanofi
11.11.1 Sanofi Company Information
11.11.2 Sanofi Dysmenorrhea Treatment Product Offered
11.11.3 Sanofi Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Sanofi Main Business Overview
11.11.5 Sanofi Latest Developments
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Company Information
11.12.2 GlaxoSmithKline Dysmenorrhea Treatment Product Offered
11.12.3 GlaxoSmithKline Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 GlaxoSmithKline Main Business Overview
11.12.5 GlaxoSmithKline Latest Developments
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Information
11.13.2 Johnson & Johnson Dysmenorrhea Treatment Product Offered
11.13.3 Johnson & Johnson Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Johnson & Johnson Main Business Overview
11.13.5 Johnson & Johnson Latest Developments
11.14 Focus Consumer Healthcare
11.14.1 Focus Consumer Healthcare Company Information
11.14.2 Focus Consumer Healthcare Dysmenorrhea Treatment Product Offered
11.14.3 Focus Consumer Healthcare Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Focus Consumer Healthcare Main Business Overview
11.14.5 Focus Consumer Healthcare Latest Developments
12 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20 10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る